Effects of protease inhibitiors on early stages of meiosis in Xenopus laevis oocytes.
D000818:Animals; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D005260:Female; D007930:Leucine / Q000378:metabolism; D008540:Meiosis / Q000187:drug effects*; D008675:Metamorphosis, Biological; D009865:Oocytes / Q000378:metabolism*; D010053:Ovary / Q000187:drug effects; D010063:Ovum / Q000378:metabolism*; D010447:Peptide Hydrolases / Q000378:metabolism; D011480:Protease Inhibitors; D014176:Protein Biosynthesis; D013997:Time Factors; D014106:Tosylarginine Methyl Ester / Q000494:pharmacology; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects; D014316:Tritium; D014981:Xenopus
D011480:Protease Inhibitors; D014316:Tritium; D014107:Tosyllysine Chloromethyl Ketone; D014106:Tosylarginine Methyl Ester; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D007930:Leucine